Pramipexole hydrochloride LA tablets 0.375 mg MI “Sawai” are manufactured by Sawai Pharmaceutical and contain Pramipexole hydrochloride hydrate. This long-acting medication is used for treating Parkinson’s disease and restless legs syndrome. Its YJ code is 1169012G1079, with a standard dosage of 0.375 mg per tablet.
Pramipexole hydrochloride LA tablets 0.375 mg MI “Sawai”
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →More with the same ingredient
